| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.1 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.067 | 0.1 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.074 | 0.2 |